Drugs / IDP-110
last change Aug 2007 re-read 2 minutes ago

IDP-110

Developed for
acne
Investigated by
Dow Pharmaceutical Sciences

Trials 2 · a red edge is where a trial was stopped

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00663286 Oct 2006 → Aug 2007 acne Dow Pharmaceutical Sciences Completed No outcome recorded
Phase 3 NCT00664248 Oct 2006 → Aug 2007 acne Dow Pharmaceutical Sciences Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as IDP-110 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00663286
1

NCT00664248